THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS NO. 596/2014 AS IT FORMS.
Dr. Coughlin has served as a Director since 2022, assuming the role of Head of Research and Development in February 2024, driving the development of the pre|CISION™ platform .